Company Description
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific.
It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property.
The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets.
In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement.
It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations.
The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020.
Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 2016 |
| Industry | Information Technology Services |
| Sector | Technology |
| Employees | 12,000 |
| CEO | Matti Shem Tov |
Contact Details
Address: 70 St. Mary Axe London, EC3A 8BE United Kingdom | |
| Phone | 44 20 7433 4000 |
| Website | clarivate.com |
Stock Details
| Ticker Symbol | CLVT |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001764046 |
| CUSIP Number | G21810109 |
| ISIN Number | JE00BJJN4441 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Jonathan M. Collins | Executive Vice President and Chief Financial Officer |
| Gordon Samson | President of Intellectual Property |
| Bar Veinstein | President of Academia and Government |
| Henry Levy | President of Life Sciences and Healthcare |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 6, 2024 | 10-Q | Quarterly Report |
| Nov 6, 2024 | 8-K | Current Report |
| Oct 15, 2024 | 144 | Filing |
| Sep 19, 2024 | 144 | Filing |
| Aug 30, 2024 | 144 | Filing |
| Aug 6, 2024 | 8-K | Current Report |
| Aug 6, 2024 | 10-Q | Quarterly Report |
| Aug 6, 2024 | 8-K | Current Report |
| Jul 24, 2024 | 8-K | Current Report |